GLP-1 Appetite Suppression: How It Works (October 2026)

01 · The core answer

Does GLP-1 work by suppressing appetite?

Yes, appetite regulation is central to how GLP-1 medicines work, but it is only part of the picture. Tirzepatide is the first treatment of its kind to activate two natural gut-hormone receptors at once: GIP and GLP-1. Together these help regulate appetite, slow how quickly the stomach empties, and improve the way the body responds to insulin.¹

In practice, most people feel fuller sooner and less hungry between meals, which supports a reduced-calorie diet.¹ The medicine makes a reduced-calorie diet easier to follow. It does not do the dieting for you, and it is not a stimulant or a fat burner.

Many people describe the change as hunger becoming quieter rather than disappearing. Food is still enjoyable, and you still need to choose what and how much to eat. Our guide to GLP-1 and appetite goes through the day-to-day experience in more detail.

02 · Your decision

The decisions you are actually facing

If you are reading about appetite suppression, you are probably weighing up one of three things: whether a licensed GLP-1 medicine is relevant to you, whether a cheaper or "natural" route could do the same job, or how to eat once your appetite changes. Each has a different answer.

Is it relevant to you? Mounjaro is licensed in the UK for weight management in adults and for type 2 diabetes.¹ NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition.⁴ Private prescribing follows the licence and a prescriber decides whether it is suitable for you after reviewing your health questionnaire. Mounjaro is a prescription-only medicine, supplied only after an online consultation reviewed by a GPhC-registered prescriber.

Could something cheaper do the same? Not in the same way. Supplements and over-the-counter products are available cheaply without assessment, but they do not act on these receptors in the way the licensed medicines do, and they carry no clinical oversight.

How should you eat? Appetite suppression is the moment to build habits. Eating enough protein and fibre, spacing meals, and staying active all matter more, not less, when you feel less hungry. Our nutrition plan for weight loss covers calories, protein, fibre and portions in practical terms.

03 · What next

A soft next step

If the mechanism fits what you are looking for, the next step is a free online consultation with a GPhC-registered prescriber, who will decide whether treatment is suitable. You can see how this works at our weight loss clinic. If you want to look at cost, your first 2.5mg pen costs £129.99 with code FIRST40 (standard price £169.99) on the Mounjaro pen page, prices checked 10 October 2026.

Treatment is used alongside a reduced-calorie diet and increased physical activity. Individual results vary, and this page is information, not a substitute for medical advice.

04 · What suppression means

What "appetite suppression" means with GLP-1 medicines

With GLP-1 medicines, appetite suppression means a reduction in hunger and an earlier sense of fullness, not a numbing or stimulant effect. That distinction separates them from older products sold as appetite suppressants, and it is worth understanding before you decide anything.

The medicine acts on the same hormone pathways your gut already uses after eating. Tirzepatide activates the GIP and GLP-1 receptors, and together these help regulate appetite, slow how quickly the stomach empties, and improve the way the body responds to insulin.¹ Appetite is therefore one effect among several, all pointing the same way.

In practice, most people feel fuller sooner and less hungry between meals, which supports a reduced-calorie diet.¹ The medicine changes how hard the diet feels. It does not remove the need for one.

People often talk about quieter "food noise", meaning the background mental chatter about the next meal or snack. How you feel will depend on you, your dose and your routine, and individual results vary.

It is also worth being clear about what suppression is not. It is not a switch you flick that works the same way for everybody. It is not instant on the first injection. And it does not make you immune to eating for comfort, boredom or habit. Hunger is only one of the reasons people eat, which is why the habits you build matter alongside the medicine.

Because the effect is hormonal rather than stimulant-based, it is delivered as a once-weekly injection through a pre-filled multi-dose pen rather than a daily tablet.¹ The pen comes in six strengths, and a prescriber guides how you move up through them.

The practical takeaway is simple. If you expect the medicine to make eating less of a daily battle, that matches how it is described in the product information. If you expect it to do the work without any change in what you eat or how active you are, that does not match the licence, which states use alongside a reduced-calorie diet and increased physical activity.

05 · The mechanism explained

The GLP-1 appetite suppression mechanism, step by step

The mechanism starts with gut hormones that signal fullness, and GLP-1 medicines copy and extend that signal. Here it is in plain steps.

Tirzepatide is the first treatment of its kind to activate two natural gut-hormone receptors at once: GIP and GLP-1.¹ Your body already makes both hormones after a meal. They are part of the conversation between your gut and the systems that regulate hunger. The medicine strengthens and prolongs that conversation.

First, appetite regulation. These receptors help regulate appetite, which is why most people feel fuller sooner and less hungry between meals.¹ Second, stomach emptying. The same action slows how quickly the stomach empties, so food stays put longer and the feeling of having eaten lasts. Third, insulin response. The medicine improves the way the body responds to insulin, which is part of why it is also licensed for type 2 diabetes.

This dual action is what distinguishes Mounjaro from single-action GLP-1 medicines such as semaglutide (Wegovy/Ozempic).¹ Semaglutide acts on the GLP-1 receptor alone. Tirzepatide activates GLP-1 and GIP together.

Why a weekly injection? Tirzepatide has a half-life of about five days, so after a final dose it takes roughly 4–5 weeks to clear the system — there is no way to speed this up, and nothing needs doing while it clears.¹ That long half-life is why one injection a week is enough to keep the effect steady, and also why changes in appetite build and fade gradually rather than overnight.

Read your patient information leaflet for the full detail on side effects and what to do about them.¹³

For a wider look at how hunger signals link to these medicines, see our GLP-1 and appetite guide.

06 · Fullness and digestion

Fullness, slower digestion and what you may notice

Slower stomach emptying is the physical half of appetite suppression, and it explains why portions often feel naturally smaller. Food stays in the stomach longer, so the sense of fullness arrives sooner and lingers.

Appetite and digestion work together. One is the brain-and-gut signalling that tells you whether you want food. The other is the physical pace at which food moves on. When both shift, many people find that a smaller meal is satisfying, and that the gap before the next bout of hunger is longer. That matches the product description of feeling fuller sooner and less hungry between meals.¹

What does this mean practically? Eating slowly becomes more useful, because fullness can arrive before you expect it. Stopping at the first comfortable sign of fullness, rather than finishing the plate by habit, is a sensible approach. Large, rich or very fatty meals may feel less comfortable than they used to, which is another reason to keep portions modest.

Read your patient information leaflet before you start, and again when you change dose.¹³ If you notice a new symptom that worries you, speak to your prescriber, and you can report suspected side effects through the MHRA Yellow Card scheme.¹⁹ Serious side effects are uncommon but need urgent attention. Seek immediate medical help for severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of skin/eyes (possible gallbladder problems); or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing.

One further point on medicines that interact with digestion. Because stomach emptying slows, the medicine can reduce absorption of oral contraceptives.⁷ The SmPC advises switching to a non-oral method, or adding a barrier method (such as condoms), for 4 weeks after starting Mounjaro and for 4 weeks after each dose increase.¹ If that applies to you, discuss it with your prescriber so that you have the right cover. Likewise, if you take insulin or a sulfonylurea, doses may need adjusting because of the risk of low blood sugar, so tell your prescriber about every medicine you use.¹¹

Finally, the timing of the effect. It builds as you move through the dose steps rather than arriving fully formed. Early on, you may notice mainly a smaller appetite at meals. Over the following weeks of titration, the effect and your routine settle. Keep a simple note of how hungry you feel and what you eat, or use the free GLPTrackr companion app to follow your journey, and bring that to your monthly review.

07 · Eating well on treatment

A nutrition plan for GLP-1s and reduced appetite

A good nutrition plan on a GLP-1 medicine focuses on making each smaller meal count, because treatment is used alongside a reduced-calorie diet and increased physical activity.¹ When appetite drops, the risk is not eating too much but eating too little of the right things.

Build meals around protein. Protein helps you feel satisfied and supports your muscles while you eat less. Include a protein source at every meal, even when you only have a small appetite. Eggs, fish, poultry, pulses, dairy and tofu all work.

Keep fibre in the plan. Vegetables, fruit, wholegrains and pulses add bulk and variety. Introduce them steadily and drink plenty of fluid alongside them. Since digestion is slower on treatment, heavily processed, greasy food may sit uncomfortably, so lighter cooking methods often suit better.

Eat small, regular meals. If fullness arrives quickly, smaller portions at planned times are easier than forcing large plates. Eat slowly, put the fork down between mouthfuls and stop at comfortable fullness.

Do not skip meals entirely. A low appetite is not a reason to go without food for long stretches. If you are struggling to eat enough, tell your prescriber at your monthly review rather than pushing on alone.

Stay hydrated. Thirst can be mistaken for hunger, and fluid helps digestion. Water, tea and other unsweetened drinks are the easy default.

Move regularly. The licence refers to increased physical activity. That does not need to mean a gym. Walking, cycling, swimming and strength work that suits you all count, and strength work is especially helpful when you are eating less.

Plan for the social side too. Meals out, family occasions and workplace food do not stop. Choosing a starter-sized portion, sharing a dessert or leaving food without guilt are skills that medicine makes easier but does not teach.

For concrete detail on calories, protein, fibre and portion sizes, see our full nutrition plan guide. Keep the aim sensible: you are building a way of eating you can sustain after treatment, because the habits you form matter most when the medicine is no longer doing part of the work.

If you have a medical condition that affects diet, such as diabetes, or you take medicines that are sensitive to changes in eating, ask your prescriber or GP to help you adjust the plan safely.

08 · What the trials show

What the trial evidence says about results

The main trial for tirzepatide in weight management is SURMOUNT-1, and its results are averages that depend on diet, activity and dose.

In the SURMOUNT-1 trial of 2,539 adults, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone.² These are trial averages — individual results vary, and treatment works alongside a reduced-calorie diet and increased physical activity, not instead of them.²

At 72 weeks, 85% of participants on 5mg, 89% on 10mg and 91% on 15mg had lost at least 5% of their body weight.² Half of participants on 10mg and 57% on 15mg lost at least 20% of their body weight.²

How should you read that? Trial averages do not predict your own result. Some people lose more, some less, and the people in a trial receive structured support that real life does not always replicate. The comparison group is the useful part: lifestyle changes alone produced a far smaller average loss than lifestyle changes combined with tirzepatide, which suggests the medicine adds something real to diet and activity.

The appetite effect is the likely route by which that happens, because feeling fuller sooner makes a reduced-calorie diet easier to follow.¹

A frequent question is how fast weight comes off, and why some people seem to lose weight so quickly. Trial results are averages over a long period and individuals differ widely. Early changes in appetite are common as you start, but rapid early loss is not a promise and should never be the goal in itself. Steady progress, supported by your monthly review, is a better indicator that things are working.

Please do not compare these results against other medicines as if head to head. Different trials use different populations and designs, and only a direct trial can support a direct comparison. If you are comparing options, our prescriber can talk you through the licensed alternatives.

Finally, keep in mind who the trial included: adults with overweight or obesity. The licence and the NICE guidance define who treatment is for, and a prescriber decides whether it is suitable for you.⁴

09 · Alternatives and shortcuts

Natural alternatives, "poor man's Ozempic" and other appetite suppressants

Nothing sold as a natural or cheap alternative acts on appetite in the way a licensed GLP-1 medicine does, and the marketing often overstates what it can do.

The nicknames are marketing. Products such as berberine are promoted as "nature's Ozempic" or a "poor man's Ozempic", usually with dramatic weight-loss claims. They are low-cost supplements with no clinical oversight, and dosing is not standardised. They are not the same medicine, and they do not activate the GLP-1 and GIP receptors the way tirzepatide does.¹ If you take any supplement, tell your prescriber and pharmacist, because supplements can still interact with other medicines.

What about foods and habits that support fullness? Protein, fibre-rich foods, adequate fluid and regular meals all help you feel satisfied, and they are free from side effects of their own. They are good practice with or without medication. Our nutrition plan guide explains how to put them together, but they will not replicate a prescription medicine.

Other approaches include acupuncture, acupressure points and caffeine. They are not equivalent to licensed medicines, and we do not suggest they will produce the same effect.

Then there are prescription stimulants. Some people ask about medicines such as the one covered on our Concerta appetite suppression page. Those are licensed for other conditions, and reduced appetite is a side effect, not a purpose. Using a medicine for weight loss outside its licence is not something we advise, and your prescriber will not recommend it as a shortcut.

Which licensed option suits whom? Wegovy (semaglutide) is another once-weekly injection, with a dose ladder of 0.25mg, 0.5mg, 1mg, 1.7mg and 2.4mg, stepping up after at least four weeks to reach the 2.4mg maintenance dose from week 17. Liraglutide is a daily injection supplied at 6mg/ml. Mounjaro is once weekly and acts on two receptors. Which suits you is a prescriber decision, so there is no single "best" GLP-1 for everyone. Our overview of prescription appetite suppression sets the options side by side.

One safety warning matters here. Be cautious of anyone offering to supply a prescription weight-loss injection without a consultation or prescription. Counterfeit and unregulated products circulate, and the MHRA publishes counterfeit alerts.⁷ Check that a pharmacy is on the GPhC register. Ours is GPhC 9012878.

10 · When treatment stops

What happens to appetite when you stop

Appetite returns gradually after stopping, because the medicine clears slowly rather than all at once. Understanding that timeline helps you plan, and it is one of the things people say they wish they had known before starting.

Tirzepatide has a half-life of about five days, so after a final dose it takes roughly 4–5 weeks to clear the system — there is no way to speed this up, and nothing needs doing while it clears.¹ During those weeks the appetite-regulating effect fades alongside the falling drug level. You may notice hunger and food thoughts creeping back over that period, rather than snapping back on a particular day.

What does the evidence say about stopping? In SURMOUNT-4, people who stopped tirzepatide after 36 weeks regained on average 14% of body weight over the following year, while those who continued treatment lost a further 5.5% on average.¹⁴ Stopping should always be planned with your prescriber, with diet and activity habits ready to carry the load.

This is why a plan for after treatment matters. If your habits are built while appetite is quiet, you are better placed when it returns. That means keeping regular meals, protein and fibre in the plan, staying active, and keeping in touch with your prescriber about how to step down or continue. Stopping suddenly without a plan is the situation to avoid.

If you want to pause, for illness, travel or any other reason, talk to your prescriber first. Mounjaro must not be used during pregnancy, and it should be stopped at least one month before trying to conceive. If you become pregnant during treatment, stop the medicine and tell your prescriber promptly. Do not restart at a high strength on your own, and never stretch or alter doses in ways that are not in the product information.

Repeat orders with us re-check suitability, with no auto-shipping, and ongoing monthly reviews, dose-titration and follow-up assessments are part of the aftercare, so you are not left to work this out alone.

11 · Serious side effects

Serious side effects: when to get help straight away

Serious side effects are uncommon but need urgent attention. Seek immediate medical help for: severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of skin/eyes (possible gallbladder problems); or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing. If you take insulin or a sulfonylurea alongside Mounjaro, watch for low blood sugar (shakiness, sweating, confusion) — your prescriber may need to adjust those medicines.¹

12 · NHS and private access

Getting a GLP-1 medicine: NHS and private routes

You can get Mounjaro through the NHS or privately, and the right route depends on your circumstances and how long you can wait. Both routes follow the same licence.

NHS. Mounjaro is available on the NHS, but access is being phased in over several years. NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition, and the NHS primary-care rollout began in June 2025 with the highest-need groups first (initially BMI 40+ with four or more qualifying conditions).⁴⁶ Full rollout is expected to take years, which is why many people who meet the licensed criteria choose regulated private treatment rather than waiting.⁵ Your GP is the best first contact to see where you sit. NHS access to Wegovy runs through specialist weight-management services, so ask your GP.

Private. A private pharmacy supplies after an online consultation reviewed by a GPhC-registered prescriber. At EverydayMeds the journey is straightforward:

• Complete a free online consultation, a short health questionnaire with no charge and no obligation.
• A GPhC-registered prescriber reviews it. Payment is taken when you place the order; if the prescriber decides the treatment is not suitable, the order is refunded automatically in full.
• Our registered pharmacy dispenses and dispatches, with same-day dispatch when ordered by 3pm, and free next-day tracked delivery in temperature-controlled packaging.

We supply genuine KwikPens through official LillyDirect supply, and all six doses are in stock. Needles, a sharps bin and injection guidance come with every order. New customers save £40 on their first order with code FIRST40, and an automatic £25 reorder discount applies to every future order (code DOSE25). The consultation is free and the price shown is the price paid.

For context on cost across the UK pharmacies we track, Mounjaro pens ranged from £143.96 to £339.00 per month across all doses as of 10 October 2026. Our current prices are on the Mounjaro pen page.

Payment options include Visa, Mastercard, Klarna and pay-monthly options, with no subscriptions. Support is available Monday to Friday, 9am to 5pm, by email at support@everydaymeds.co.uk, account portal chat or phone on 0333 207 0413.

Treatment is used alongside a reduced-calorie diet and increased physical activity, and individual results vary. Whether through the NHS or privately, a prescriber should make the final decision on suitability for you.